Mochizuki Yoshiko
Dokkyo University School of Medicine, Department of Obstetrics and Gynecology.
Clin Calcium. 2006 Jun;16(6):948-55.
Tartrate-resistant acid phosphatase (TRACP) is a well-known marker for bone resorption, but it is not enough for clinical use in specificity of bone and instability in serum. Tartrate-resistant acid phosphatase type 5b (TRACP-5b) is an osteoclast-produced enzyme and was reported the clinical performance of a novel fragments absorbed immunocapture enzyme assay. TRACP-5b have smaller day-to-day and diurnal variation than those of urinary bone resorption markers and show the usefulness as promising markers in monitoring the treatment for osteoporosis.
抗酒石酸酸性磷酸酶(TRACP)是一种广为人知的骨吸收标志物,但在骨特异性和血清稳定性方面,它不足以用于临床。5b型抗酒石酸酸性磷酸酶(TRACP-5b)是破骨细胞产生的一种酶,有报道称其在一种新型片段吸收免疫捕获酶测定中的临床性能。与尿骨吸收标志物相比,TRACP-5b的日常和昼夜变化较小,在监测骨质疏松症治疗方面显示出有望成为有价值的标志物。